These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8638041)

  • 1. Risk assessment of nongenotoxic carcinogens based upon cell proliferation/death rates in rodents.
    Gaylor DW; Zheng Q
    Risk Anal; 1996 Apr; 16(2):221-5. PubMed ID: 8638041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay.
    Lutz WK; Kopp-Schneider A
    Toxicol Sci; 1999 May; 49(1):110-5. PubMed ID: 10367348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
    Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
    IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zonal differences in DNA synthesis activity and cytochrome P450 gene expression in livers of male F344 rats treated with five nongenotoxic carcinogens.
    Chen ZY; White CC; He CY; Liu YF; Eaton DL
    J Environ Pathol Toxicol Oncol; 1995; 14(2):83-99. PubMed ID: 9372837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.
    Melnick RL; Huff J
    Toxicol Ind Health; 1993; 9(3):415-38. PubMed ID: 8367884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell proliferation not associated with carcinogenesis in rodents and humans.
    Ward JM; Uno H; Kurata Y; Weghorst CM; Jang JJ
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):125-35. PubMed ID: 8013399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on the risk assessment for nongenotoxic carcinogens and tumor promoters.
    Perera FP
    Environ Health Perspect; 1991 Aug; 94():231-5. PubMed ID: 1954932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence.
    Luke NS; Sams R; DeVito MJ; Conolly RB; El-Masri HA
    Toxicol Sci; 2010 May; 115(1):253-66. PubMed ID: 20106946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation.
    Tan YM; Butterworth BE; Gargas ML; Conolly RB
    Toxicol Sci; 2003 Sep; 75(1):192-200. PubMed ID: 12805651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologically bounded risk assessment for receptor-mediated nongenotoxic carcinogens.
    Gastel JA; Sutter TR
    Regul Toxicol Pharmacol; 1995 Dec; 22(3):273-82. PubMed ID: 8837852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanistic approach to modelling the risk of liver tumours in mice exposed to fumonisin B1 in the diet.
    Kodell RL; Young JF; Delongchamp RR; Turturro A; Chen JJ; Gaylor DW; Howard PC; Zheng Q
    Food Addit Contam; 2001 Mar; 18(3):237-53. PubMed ID: 11304033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universality of J-shaped and U-shaped dose-response relations as emergent properties of stochastic transition systems.
    Cox LA
    Dose Response; 2006 May; 3(3):353-68. PubMed ID: 18648616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.
    Yamasaki H; Ashby J; Bignami M; Jongen W; Linnainmaa K; Newbold RF; Nguyen-Ba G; Parodi S; Rivedal E; Schiffmann D; Simons JW; Vasseur P
    Mutat Res; 1996 Jun; 353(1-2):47-63. PubMed ID: 8692192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
    Dragan YP; Hully J; Baker K; Crow R; Mass MJ; Pitot HC
    Toxicology; 1995 Sep; 102(1-2):161-75. PubMed ID: 7482551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation in carcinogenesis.
    Cohen SM; Ellwein LB
    Science; 1990 Aug; 249(4972):1007-11. PubMed ID: 2204108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
    Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.